Close

ADC Therapeutics Announces Exclusive License with Mitsubishi Tanabe Pharma Corporation to Develop and Commercialize ZYNLONTA® (loncastuximab tesirine-lpyl) in Japan

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 4/19/2024

1. NFLX
2. TSM
3. ISRG
4. SPY
5. INFY
6. SNV
7. TSLA
8. SMCI
9. SLB
10. PPG


Go back to ADC Therapeutics Announces Exclusive License with Mitsubishi Tanabe Pharma Corporation to Develop and Commercialize ZYNLONTA® (loncastuximab tesirine-lpyl) in Japan
ADC TELECOMM (NYSE: ADCT) Delayed: 4.68 -0.08 (1.68%)
Previous Close $4.76    52 Week High $12.76 
Open $4.76    52 Week Low $5.18 
Day High $4.92    P/E 6.00 
Day Low $4.65    EPS $0.78 
Volume 223,721